HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complementation Group C Xeroderma Pigmentosum

mutation in XPC gene
Also Known As:
Xeroderma Pigmentosum, Complementation Group C; XP, Group C; XP3; XPCC; Xeroderma Pigmentosum III
Networked: 100 relevant articles (0 outcomes, 7 trials/studies)

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Xeroderma Pigmentosum (Kaposi's Disease)
4. Nijmegen Breakage Syndrome
5. Lung Neoplasms (Lung Cancer)

Experts

1. Chen, Jyh-Cheng: 3 articles (01/2021 - 01/2018)
2. Lin, Yun-Wei: 3 articles (01/2021 - 01/2018)
3. Emmert, S: 3 articles (08/2001 - 10/2000)
4. Khan, S G: 3 articles (08/2001 - 10/2000)
5. Kraemer, K H: 3 articles (08/2001 - 10/2000)
6. Chen, Tzu-Ying: 2 articles (01/2021 - 11/2018)
7. Qu, Meihua: 2 articles (01/2021 - 04/2015)
8. Yen, Ting-Chuan: 2 articles (01/2021 - 11/2018)
9. Lin, Yuan-Cheng: 2 articles (11/2018 - 01/2018)
10. Ma, Peng-Fang: 2 articles (11/2018 - 01/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Complementation Group C Xeroderma Pigmentosum:
1. RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
2. Proteins (Proteins, Gene)FDA Link
3. Messenger RNA (mRNA)IBA
4. Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
5. Peptides (Polypeptides)IBA
6. Codon (Codons)IBA
7. Adenosine Triphosphatases (ATPase)IBA
8. Complex MixturesIBA
9. PlatinumIBA
10. Anesthetics (Anesthetic Agents)IBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Mohs Surgery (Mohs' Micrographic Surgery)
3. Radiotherapy